Letter to the Editor: Is Emricasan (IDN-6556), an Oral Pan-Caspase Inhibitor, Ready for Controlled Trials?

Hepatology

Department of Gastroenterology and Hepatology, Geisinger Clinic, Danville, PA.

Published: September 2019

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.30683DOI Listing

Publication Analysis

Top Keywords

letter editor
4
editor emricasan
4
emricasan idn-6556
4
idn-6556 oral
4
oral pan-caspase
4
pan-caspase inhibitor
4
inhibitor ready
4
ready controlled
4
controlled trials?
4
letter
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!